Efficacy and safety of sorafenib for advanced renal cell carcinoma: Real-world data of patients with renal impairment

Katsunori Tatsugami, Mototsugu Oya, Koki Kabu, Hideyuki Akaza

Research output: Contribution to journalArticle

8 Citations (Scopus)

Fingerprint Dive into the research topics of 'Efficacy and safety of sorafenib for advanced renal cell carcinoma: Real-world data of patients with renal impairment'. Together they form a unique fingerprint.

Medicine & Life Sciences